CorMedix Inc. (NASDAQ: CRMD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CORMEDIX INC.

CorMedix Inc. (NASDAQ: CRMD)
Listen to this Section


$8.47
-0.0750 ( -0.88% ) 473.8K

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Clinical Trial Pipeline Stages


Drug Name Stage
DefencathDetailsInfectious disease, Catheter related blood stream infections Approved

Market Data


Open $8.47
Previous Close $8.54
Volume 473.8K
Market Cap $645.66M
Day Range $8.13 - $8.67
52 Week Range $6.13 - $17.43
Shares Outstanding 78.45M
Change % -0.88%
Net Change ▼ -0.0750
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2010
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -501,254.00

Date Type Amount Purchased Purchaser
2024-01-17 Sale -133333.00 Todisco Joseph
2024-01-17 Sale -50000.00 Mistry Erin
2024-01-17 Sale -50000.00 David Matthew T
2024-01-17 Sale -50000.00 Masson-Hurlburt Elizabeth
2023-12-18 Buy 3000.00 DUNTON ALAN W
2023-12-14 Sale -50000.00 Zelnick Kaufman Beth
2023-11-21 Buy 1000.00 Mistry Erin
2023-11-17 Sale -15000.00 Lefkowitz Steven W
2023-09-08 Buy 10000.00 Todisco Joseph

SEC Filings


Form Type Description Pages Date
144 Insider transactions 1 Nov 14, 2025
s-8 Registration statements 16 Nov 13, 2025
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 90 Nov 12, 2025
4 Insider transactions 1 Oct 27, 2025
def Proxies and info statements 3 Oct 24, 2025
8-k 8K-related 14 Oct 20, 2025
8-k/a 8K-related 19 Sep 30, 2025
4 Insider transactions 1 Sep 18, 2025
4 Insider transactions 1 Sep 16, 2025

Latest News


× Before browsing our site, please accept our cookies policy